Peter Marks was a natural fit for a new White House project tasked with developing a coronavirus vaccine. The cancer specialist spent nearly a decade at the Food and Drug Administration, most recently overseeing the office that approves vaccines and gene therapies. But Marks quit last month just days after joining President Donald Trump’s Operation Warp Speed, a venture partnering government with private companies in the vaccine race. He returned to his old FDA job full time after a clash with White House coronavirus coordinator Deborah Birx about how the government was prioritizing potential vaccines during a tense meeting of the White House coronavirus task force, according to three people familiar with the event.

 

Read more…